DeBarbieri A, Crovari P, Cuneo-Crovari P, Badolati G, Giacometti G
Dev Biol Stand. 1976;33:213-9.
151 subjects, vaccinated by oral route with live influenza viruses attenuated in the USSR (bivalent A/England/42/72-B/Hong Kong/5/72 vaccine) and 66 non-vaccinated cohabitants have been studied. The vaccination did not cause any important side effect. The vaccine showed good immunizing activity: HI antibodies appeared in 91% of the subjects initially devoid of antibodies against A type and in 70% against B type. No viral diffusion occurred from the vaccinated to the cohabitants. During an A/Port Chalmers/1/73 epidemic the morbidity (3.3%) among the orally vaccinated patients turned out significantly lower than that among the non-vaccinated cohabitants (12.1%). The protection index was 72.6%.
对151名通过口服途径接种了苏联研制的减毒活流感病毒(二价A/英格兰/42/72 - B/香港/5/72疫苗)的受试者以及66名未接种疫苗的同居者进行了研究。接种疫苗未引起任何严重的副作用。该疫苗显示出良好的免疫活性:在最初缺乏A型抗体的受试者中,91%出现了血凝抑制(HI)抗体,在缺乏B型抗体的受试者中,70%出现了HI抗体。未发生从接种疫苗者向同居者的病毒传播。在A/查尔姆斯港/1/73疫情期间,口服疫苗接种患者的发病率(3.3%)显著低于未接种疫苗的同居者(12.1%)。保护指数为72.6%。